From Casetext: Smarter Legal Research

Axcan Scandipharm Inc. v. Ethex Corporation

United States District Court, D. Minnesota
Aug 9, 2007
Civ. No. 07-2556 (RHK/JSM) (D. Minn. Aug. 9, 2007)

Opinion

Civ. No. 07-2556 (RHK/JSM).

August 9, 2007


ORDER


This matter is before the Court on Plaintiff's Unopposed Motion to Consolidate Briefing (Doc. No. 49). Plaintiff seeks permission to file one memorandum, limited to 18,000 words, in response to Defendants ETHEX Corporation's and KV Pharmaceutical Company's Motion for Judgment on the Pleadings and Defendants Global Pharmaceutical's and Impax Laboratories, Inc.'s Motion to Dismiss. The Court having considered the Motion and concluding that the relief requested therein is appropriate, IT IS ORDERED that Plaintiff's Motion is GRANTED.


Summaries of

Axcan Scandipharm Inc. v. Ethex Corporation

United States District Court, D. Minnesota
Aug 9, 2007
Civ. No. 07-2556 (RHK/JSM) (D. Minn. Aug. 9, 2007)
Case details for

Axcan Scandipharm Inc. v. Ethex Corporation

Case Details

Full title:Axcan Scandipharm Inc., Plaintiff, v. ETHEX Corporation, et al., Defendants

Court:United States District Court, D. Minnesota

Date published: Aug 9, 2007

Citations

Civ. No. 07-2556 (RHK/JSM) (D. Minn. Aug. 9, 2007)